Human soluble tumor necrosis factor receptor I (sTNF-RI) and interleukin-I receptor antagonist (IL-I Ra) in different stages of acute rheumatic fever
Makaleler > Tam Makale · 2008
Yazarlar: Necil KÜTÜKÇÜLER, Neslihan KARACA, Betul Y. Sozeri, Gueldane Koturoglu, Nuri Zafer KURUGÖL, Ruhi A. Ozyurek, Güzide AKSU
ANATOLIAN JOURNAL OF CARDIOLOGY, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2008, cilt 8, ss 139-142
Özet
Objective: Acute rheumatic fever (ARF) results from an autoimmune response to infection with group A streptococci. Serum concentrations of two anti-inflammatory cytokines, interleukin-I receptor antagonist (IL-IRa) and human soluble tumor necrosis factor receptor I (sTNF-RI) were determined in patients with ARF at the time of admission and 3 months after treatment in order to evaluate changes in cytokine concentrations occurring during different stages of the disease.